CAS: 58-94-6; Chlorothiazide

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

chloraminophenamide formic acid formaldehyd 2,4-Disulfamoyl-5-chlor-formanilid4-amino-6-chloro-benzene-1,3-disulfonic acid 1-amide 3-ethylamide 6-Chlor-1,2,4-benzothiadiazin-1,1-dioxid-7- 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide 6-benzo[1,2,4]thiadiazine-7-sulfonic acid amide1,1-dioxo-6-phenylsulfanyl-1,2(4)-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid amide

合成工艺路线路线简述

  • 合成目标产物 Chlorothiazide 主要起始原料 4-Amino-6-Chlorobenzene-1,3-Disulfonamide And Formic Acid
  • (文献来源)合成步骤主要原料 4-Amino-6-Chlorobenzene-1,3-Disulfonamide 和 Formic Acid
2,4-Disulfamoyl-5-Chlor-Formanilid 以 水 作为反应溶剂,化学反应生成 氯噻嗪
参考文献:一些带有磺酰硫脲部分的 1,2,4-苯并噻二嗪 1,1-二氧化物的合成,表征和抗氧化活性研究
标题:一些带有磺酰硫脲部分的 1,2,4-苯并噻二嗪 1,1-二氧化物的合成,表征和抗氧化活性研究
摘要:使用六种抗氧化分析法合成,表征和筛选了一系列带有磺酰硫脲部分的 1,2,4-苯并噻二嗪-1,1-二氧化物的抗氧化活性.
DOI:10.1139/cjc-2019-0194

海关参考信息

专利信息


专利号:US-2024287520-A1
优先权日:2021-06-30
标题:Method for synthesis of linkage modified oligomeric compounds
发明人:RODRIGUEZ ANDREW A
权利人:IONIS PHARMACEUTICALS INC
摘要:The present disclosure provides methods of synthesizing modified oligonucletodies and oligomeric compounds (including oligomeric compounds that are antisense agents or portions thereof) comprising a modified oligonucleotide having at least one modified internucleoside linking group. In certain embodiments, the present disclosure provides stabilized formulations of certain sulfonyl azides for use in the synthesis of olignonucleotides comprising one or more sulfonyl phosphoramidate linkages. Some embodiments provide stabilized compositions of high energy reagents that may be used in the synthesis of modified oligonucleotides, allowing for safe process scale preparation thereof.

专利号:US-2004242897-A1
优先权日:2002-07-31
标题 :Universal support media for synthesis of oligomeric compounds
发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH
摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

专利号:WO-2004011474-A1
优先权日:2002-07-31
标题:Universal support media for synthesis of oligomeric compounds
发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
权利人:ISIS PHARMACEUTICALS INC; GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotide and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

专利号:US-6653468-B1
优先权日:2002-07-31
标 题 :Universal support media for synthesis of oligomeric compounds
发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH
权利人:ISIS PHARMACEUTICALS INC
摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

专利号:US-10925977-B2
优先权日:2006-10-05
标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

专利号:US-10973847-B2
优先权日:2017-06-30
标题 :Core-to-surface polymerization for the synthesis of star polymers and uses thereof
发明人:JOHNSON JEREMIAH A; GOLDER MATTHEW R
权利人:MASSACHUSETTS INST TECHNOLOGY
摘要:Disclosed are methods, compositions, reagents, systems, and kits to prepare star polymers, as well as compositions and uses thereof. Various embodiments show that synthesis of these polymers contain low metal concentration to provide polymers for diverse biomedical applications including in vivo applications.
苏州市立德化学有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.leaderchem.com
电话: 0512-68412652 68087787👤
📞苏州市立德化学有限公司 ⚠️参考联系方式

销售电话:0512-68412652 68087787
邮箱:sales@leaderchem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
赤峰艾克制药科技股份有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.arker.com.cn
电话: 0476-8220200👤
📞赤峰艾克制药科技股份有限公司 ⚠️参考联系方式

销售电话:0476-8220200
邮箱:kykfb@arker.com.cn
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501520/ doi: 10.1159/000490687. Epub 2018 Jun 15. doi: 10.1016/j.watres.2018.05.045. Epub 2018 May 25. doi: 10.1080/23808993.2018.1420419. Epub 2018 Jan 3.
7: Katsi V, Athanasiadi E, Tsioufis C, Tousoulis D. Azilsartan and Chlorthalidone-new Powerful Fixed dose Antihypertensive Combination. Curr Hypertens Rev. 2018;14(1):15-20. doi: 10.2174/1573402114666180420170816. doi: 10.1097/MD.0000000000010500.
9: Fayed AS, Rezk MR, Marzouk HM, Abbas SS. A Capillary Zone Electrophoresis Method with Multiresponse Chemometric Optimization for the Simultaneous Determination of Zofenopril Calcium and Hydrochlorothiazide in Presence of Hydrochlorothiazide Major Impurities. J Chromatogr Sci. 2018 Mar 15. doi: 10.1093/chromsci/bmy014. [Epub ahead of print] doi: 10.1177/0003489418763224. Epub 2018 Mar 16. doi: 10.1071/HC16038. doi: 10.5863/1551-6776-23.1.26.

合成参考文献


参考文献:10.1007/s00216-010-3484-3
摘要:Peters RJB, Oosterink JE, Stolker AAM, Georgakopoulos C, Nielen MWF. Generic sample preparation combined with high-resolution liquid chromatography–time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories. Analytical and Bioanalytical Chemistry. 2010 Feb 16;396(7):2583–98. doi: 10.1007/s00216-010-3484-3.
摘要:Bariso CR, Hanenson IB, Gaffney TE. A comparison of the antihypertensive effects of furosemide and chlorothiazide. Curr Ther Res Clin Exp. 1970 Jun;12(6):333–40.
摘要:McMahon FG. Uricosurics and xanthine oxidase inhibitors: a single-dose assay. Curr Ther Res Clin Exp. 1970 Jun;12(6):414–7.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知